Adana Acıbadem Hospital Oncology Department
About Adana Acıbadem Hospital Oncology Department
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
8
Janssen Research & Development, LLC
2
Pfizer
2
Amgen
1
Bayer
1
Catalyst Biosciences
1
Freeline Therapeutics
1
Yuzuncu Yıl University
1
Clinical Trials at Adana Acıbadem Hospital Oncology Department
During the past decade, Adana Acıbadem Hospital Oncology Department conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 2 clinical trials were completed, i.e. on
average, 11.8% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia
2015-02-16
2026-02-22
Recruiting
118
Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Participants Previously Treated With Platinum-Based Chemotherapy and Crizotinib
2015-11-03
2018-08-13
Completed
119
A Study of Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors
2016-07-22
2020-11-11
Completed
88
A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer
2017-07-05
2024-06-12
Recruiting
200
A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer
2018-04-05
2024-01-31
Active, not recruiting
125
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
2018-08-02
2025-08-24
Active, not recruiting
2,300
A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations
2019-08-01
2022-09-19
Completed
3,679
AAV Gene Therapy Screening/Observational Protocol (ECLIPSE)
2020-02-14
2022-10-10
Completed
37
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Adana Acıbadem Hospital Oncology Department" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Janssen Research & Development, LLC" with 2 trials
sponsored, "Pfizer" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Bayer"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Adana Acıbadem Hospital Oncology Department"
#1 collaborator was "Acıbadem Adana Hospital" with 1 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator and "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at Adana Acıbadem Hospital Oncology Department
According to Clinical.Site data, the most researched conditions in "Adana Acıbadem Hospital Oncology Department" are
"Hemophilia A" (4 trials), "Hemophilia B" (2 trials), "Acute Lymphoblastic Leukemia (ALL)" (1 trials), "Biliary Tract Cancer" (1 trials) and "Blood Coagulation Disorder" (1 trials). Many other conditions were trialed in "Adana Acıbadem Hospital Oncology Department" in a lesser frequency.
Clinical Trials Intervention Types at Adana Acıbadem Hospital Oncology Department
Most popular intervention types in "Adana Acıbadem Hospital Oncology Department" are "Drug" (10 trials), "Biological" (4 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (3 trials), "Alectinib" (2 trials), "Cisplatin" (2 trials), "Cyclophosphamide" (2 trials) and "Emicizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Adana Acıbadem Hospital Oncology Department
The vast majority of trials in "Adana Acıbadem Hospital Oncology Department" are
13 trials for "All" genders and 4 trials for "Male" genders.
Clinical Trials Status at Adana Acıbadem Hospital Oncology Department
Currently, there are NaN active trials in "Adana Acıbadem Hospital Oncology Department".
undefined are not yet recruiting,
7 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Adana Acıbadem Hospital Oncology Department,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Adana Acıbadem Hospital Oncology Department, 2 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".